Telemonitoring Platforms and Chemotherapy-Associated Toxicity

Launched by UNIVERSIDAD NACIONAL ANDRES BELLO · Oct 4, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how a special telemonitoring app can affect the satisfaction and quality of life of adult cancer patients receiving chemotherapy. The goal is to see if using this app makes patients feel better about their healthcare experience compared to those who only have regular in-person check-ups. Participants will be adults over 18 years old with certain types of cancer, like lung or breast cancer, who can speak Spanish and own a smartphone.

If you join the study, you'll use the app to help track your health and communicate with your healthcare team. This trial is currently recruiting patients and will take place at specific hospitals from November 2023 to July 2024. It’s important to note that if you are receiving radiation therapy, have sensory or cognitive impairments, or do not want to participate, you won’t be eligible for this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients (\>18 years)
• • Histologically confirmed diagnosis of lung, gastric, gallbladder, colon, breast, or cervical carcinoma in any of its forms and stages
• • Initiating an outpatient curative intent chemotherapy regimen within the facilities of UC-Christus Health Network or Hospital Sotero del Río during the months of November 2023 to July 2024
• • Proficient in the Spanish language
• • Possess a smartphone, regardless of the native operating system (iOS® or Android®)
• Exclusion Criteria:
• • Individuals undergoing concomitant radiotherapy
• • Those with any form of sensory impairment hindering the use of the application
• • Those with cognitive impairment or psychiatric pathology preventing the use of the application
• • Those who do not wish to participate in the study